CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in APLS — Apellis Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
675,864
+4.9% QoQ
Ownership
0.528%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in APLS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 675,864 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 644,445 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | — | 647,082 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | — | 989,143 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | — | 964,499 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | — | 996,748 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | — | 956,362 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | — | 947,034 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | — | 924,562 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | — | 904,409 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | — | 879,357 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | — | 828,522 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | — | 983,509 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | — | 982,927 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | — | 948,759 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | — | 678,401 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | — | 655,308 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | — | 591,914 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | — | 518,811 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | — | 418,666 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | — | 404,127 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | — | 375,499 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | — | 369,428 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | — | 362,289 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | — | 331,083 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||